Arrowgrass Capital Partners (US)’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Arrowgrass Capital Partners (US)'s MRK Position: Q1 2018 in Review
Arrowgrass Capital Partners (US) sold out of Merck (MRK) in Q1 2018, closing a stake of 159,612 shares — an estimated $8.57M sold.
Arrowgrass Capital Partners (US) first reported a position in MRK in Q4 2013 and held it in 16 quarters. The position peaked at $15.3M in Q4 2016. 1,992 funds tracked by Wall St. Rank hold MRK as of Q1 2018.
- Arrowgrass Capital Partners (US) reported no remaining Merck position as of Q1 2018 after selling out during the quarter.
- Arrowgrass Capital Partners (US) sold 159,612 Merck shares in Q1 2018, an estimated $8.57M.
- Arrowgrass Capital Partners (US) first reported a position in Merck in Q4 2013 and held it in 16 quarters.
- Arrowgrass Capital Partners (US)'s Merck position peaked at $15.3M in Q4 2016.
- 1,992 funds tracked by Wall St. Rank held Merck as of Q1 2018.
Based on Arrowgrass Capital Partners (US)'s 13F filing for Q1 2018, filed 15 May 2018.